Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Abacus Bidco Oy (which is the parent company of Accountor Software recently acquired by KKR) in the acquisition of certain subsidiaries and assets of 24SevenOffice Group AB (“24SevenOffice”)
Mandate

Vinge advises Abacus Bidco Oy (which is the parent company of Accountor Software recently acquired by KKR) in the acquisition of certain subsidiaries and assets of 24SevenOffice Group AB (“24SevenOffice”)  

November 13, 2024 M&A Capital Markets and Public M&A Carve-Outs

24SevenOffice is a listed company (First North Stockholm) that provides modular software for accounting, ERP and business services that automate processes using AI.

The transaction primarily relates to ERP-related subsidiaries and assets, including 24SevenOffice Norway AS, 24SevenOffice Scandinavian Systems and 24SevenOffice Sweden AB. Following completion of the transaction, the acquired assets and subsidiaries will be integrated with Accountor Software.

The purchase price for the ERP-related subsidiaries and assets corresponds to an enterprise value of approximately SEK 2.4 billion.

The transaction is subject to approval by the shareholders of 24SevenOffice and regulatory approval.

Vinge's team consisted primarily of Christina Kokko, Matthias Pannier, Gustav Persson and Ian Linde (M&A), Sofie Bjärtun and Joel Magnusson (Capital Markets and Public M&A), Johan Gavelin (IP), Alice Göransson (Employment), Madelene Andersson (Real Estate), Daniel Wendelsson (FDI), Christoffer Nordin and Katja Häglund (Commercial Agreements), Nicklas Thorgerzon (IT and GDPR), Calle Tengwall Pagels and William Carlberg Johansson (Banking and Finance), Caroline Krassén (Financial Services), Caroline Löv and Filippa Bergkvist (Transaction Support).

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026